Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells

Peptides

Volumn 31, Issue 12, 2010, Pages 2276-2283

  Castorina, Alessandro ^a   Giunta, Salvatore ^a   Mazzone, Venera ^a   Cardile, Venera ^a   D'Agata, Velia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Endothelial cells; Hyperglycemia; PACAP; Proliferation; VIP

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HYPERGLYCEMIA; MICROVASCULAR ENDOTHELIAL CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HYPERGLYCEMIA; MICE; MICROVESSELS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOACTIVE INTESTINAL PEPTIDE;

MURINAE;

EID: 78049469157     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.08.013     Document Type: Article

References (35)

1. A. Absood, B. Hu, N. Bassily, and L. Colletti VIP inhibits human HepG2 cell proliferation in vitro Regul Pept 146 2008 285 292
2. A. Arimura Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems Jpn J Physiol 48 1998 301 331
3. D. Aronson Hyperglycemia and the pathobiology of diabetic complications Adv Cardiol 45 2008 1 16
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
5. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
6. A. Castorina, A. Tiralongo, S. Giunta, M.L. Carnazza, G. Rasi, and V. D'Agata PACAP and VIP prevent apoptosis in schwannoma cells Brain Res 1241 2008 29 35
7. T. Dalsgaard, J. Hannibal, J. Fahrenkrug, C.R. Larsen, and B. Ottesen VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries Regul Pept 110 2003 179 188
8. L. Dickson, and K. Finlayson VPAC and PAC receptors: from ligands to function Pharmacol Ther 121 2009 294 316
9. S. Di Paolo, L. Gesualdo, E. Ranieri, G. Grandaliano, and F.P. Schena High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells Am J Pathol 149 1996 2095 2106
10. C. Esposito, Z.H. Liu, G.E. Striker, C. Phillips, N.Y. Chen, and W.Y. Chen Inhibition of diabetic nephropathy by a GH antagonist: a molecular analysis Kidney Int 50 1996 506 514
11. J. Fahrenkrug, J. Hannibal, J. Tams, and B. Georg Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves J Cereb Blood Flow Metab 20 2000 1205 1214
12. C. Garlanda, C. Parravicini, M. Sironi, M. De Rossi, R. Wainstok de Calmanovici, and F. Carozzi Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors Proc Natl Acad Sci U S A 9 1994 7291 7295
13. S. Giunta, A. Castorina, A. Adorno, V. Mazzone, M.L. Carnazza, and V. D'Agata PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells Neuropeptides 44 2010 45 51
14. B. Guerci, P. Böhme, A. Kearney-Schwartz, F. Zannad, and P. Drouin Endothelial dysfunction and type 2 diabetes. Part 2. Altered endothelial function and the effects of treatments in type 2 diabetes mellitus Diabetes Metab 27 2001 436 447
15. A.J. Harmar, W.J. Sheward, C.F. Morrison, B. Waser, M. Gugger, and J.C. Reubi Distribution of the VPAC2 receptor in peripheral tissues of the mouse Endocrinology 145 2004 1203 1210
16. U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, and M. Hartmann Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ Res 88 2001 E14 E22
17. K. Isobe, I. Tatsuno, T. Yashiro, T. Nanmoku, K. Takekoshi, and Y. Kawakami Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis Regul Pept 110 2003 213 217
18. F. Jamen, T. Bouschet, J.C. Laden, J. Bockaert, and P. Brabet Up-regulation of the PACAP type-1 receptor (PAC1) promoter by neurotrophins in rat PC12 cells and mouse cerebellar granule cells via the Ras/mitogen-activated protein kinase cascade J Neurochem 82 2002 1199 1207
19. D.M. Jaworski Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury Cell Tissue Res 300 2000 219 230
20. S.C. Jones, H.J. Saunders, W. Qi, and C.A. Pollock Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells Diabetologia 42 1999 1113 1119
21. M. Knutsson, and L. Edvinsson Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia NeuroReport 13 2002 507 509
22. J. Li, H.B. Jin, Y.M. Sun, Y. Su, and L.F. Wang KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion Biochem Biophys Res Commun 392 2010 516 519
23. Y.M. Li, T. Schilling, P. Benisch, S. Zeck, J. Meissner-Weigl, and D. Schneider Effects of high glucose on mesenchymal stem cell proliferation and differentiation Biochem Biophys Res Commun 363 2007 209 215
24. D.K. Meyer, C. Fischer, U. Becker, I. Göttsching, S. Boutillier, and C. Baermann Pituitary adenylyl cyclase-activating polypeptide 38 reduces astroglial proliferation by inhibiting the GTPase RhoA J Biol Chem 280 2005 25258 25266
25. A. Pascale, I. Fortino, S. Covoni, M. Trabucchi, W.C. Wetsel, and F. Battaini Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex J Neurochem 67 1996 2471 2477
26. C. Premanand, M. Rema, M.Z. Sameer, M. Sujatha, and M. Balasubramanyam Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions Invest Ophthalmol Vis Sci 47 2006 2179 2184
27. J.C. Reubi In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications Ann N Y Acad Sci 921 2000 1 25
28. D. Ribatti, M.T. Conconi, and G.G. Nussdorfer Nonclassic endogenous novel regulators of angiogenesis Pharmacol Rev 59 2007 185 205
29. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101 1108
30. M.J. Sheetz, and G.L. King Molecular understanding of hyperglycemia's adverse effects for diabetic complications JAMA 288 2002 2579 2588
31. N. Sonenberg, and A.G. Hinnebusch Regulation of translation initiation in eukaryotes: mechanisms and biological targets Cell 136 2009 731 745
32. O.I. Stenina Regulation of vascular genes by glucose Curr Pharm Des 11 2005 2367 2381
33. R.C. St Hilaire, S.N. Murthy, P.J. Kadowitz, and J.R. Jeter Jr. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation Peptides 31 2010 1517 1522
34. J.R. Williamson, and C. Kilo Capillary basement membrane in diabetes Diabetes 32 1983 96 100
35. C.J. Zhou, S. Shioda, T. Yada, N. Inagaki, S.J. Pleasure, and S. Kikuyama PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways Curr Protein Pept Sci 3 2002 423 439